BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 18434587)

  • 1. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
    Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
    J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
    Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
    J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
    Yadav HN; Singh M; Sharma PL
    Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection of the aged rat heart by GSK-3beta inhibitor is attenuated: age-related changes in mitochondrial permeability transition pore modulation.
    Zhu J; Rebecchi MJ; Glass PS; Brink PR; Liu L
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H922-30. PubMed ID: 21217064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenticular mitoprotection. Part B: GSK-3β and regulation of mitochondrial permeability transition for lens epithelial cells in atmospheric oxygen.
    Brooks MM; Neelam S; Cammarata PR
    Mol Vis; 2013; 19():2451-67. PubMed ID: 24319338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
    Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
    J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ceiling effect of pharmacological postconditioning with the phytoestrogen genistein is reversed by the GSK3beta inhibitor SB 216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione] through mitochondrial ATP-dependent potassium channel opening.
    Couvreur N; Tissier R; Pons S; Chenoune M; Waintraub X; Berdeaux A; Ghaleh B
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1134-41. PubMed ID: 19318592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
    Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.
    Park SS; Zhao H; Mueller RA; Xu Z
    J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
    Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
    Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart.
    Zhu J; Rebecchi MJ; Tan M; Glass PS; Brink PR; Liu L
    J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):611-9. PubMed ID: 20427381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
    Gross ER; Hsu AK; Gross GJ
    Basic Res Cardiol; 2007 Jul; 102(4):341-9. PubMed ID: 17450314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.
    Feng J; Lucchinetti E; Ahuja P; Pasch T; Perriard JC; Zaugg M
    Anesthesiology; 2005 Nov; 103(5):987-95. PubMed ID: 16249673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
    Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C
    Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
    Miura T; Tanno M
    Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.